Entering text into the input field will update the search result below

Champions Oncology EPS in-line, beats on revenue

  • Champions Oncology (NASDAQ:CSBR): Q2 Non-GAAP EPS of $0.01 in-line; GAAP EPS of -$0.01 misses by $0.02.
  • Revenue of $11.3M (+11.7% Y/Y) beats by $0.33M.
  • Shares +7.92%.
  • Press Release

Recommended For You

More Trending News

About CSBR Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CSBR--
Champions Oncology, Inc.